Capricor

$5.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+2.67%) Today

-$0.06 (-1.11%) As of 9:52 PM UTC after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, and ETFs commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. The listed name for CAPR is Capricor Therapeutics, Inc. Common Stock.

CEO

Linda Marbán

Employees

Headquarters

Beverly Hills, California

Founded

2005

Market Cap

101.10M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.02M

High Today

$5.47

Low Today

$4.97

Open Price

$5.25

Volume

663.53K

52 Week High

$12.32

52 Week Low

$0.88

Collections

CAPR Earnings

-$0.70

-$0.47

-$0.23

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 17, After Hours